Skip to main content
. 2021 Aug 11;12:713265. doi: 10.3389/fmicb.2021.713265

Table 1.

Characteristics of the 39 patients developing microscopically proven Pneumocystis pneumonia.

Patient no. Age (years) Gender Underlying condition 30-day outcome PCR Ct value in BALF sample Serum BG level (pg/ml) Time between serum and BALF sampling (days)
Patients with systemic autoimmune or inflammatory disorder
P1§ 59 F Sarcoidosis Survived 19 3,480 4
P9*,# 69 M Psoriatic arthritis Died 27 4,550 1
P15 65 M Drug-induced interstitial lung disease Died 26 193 0
P26§ 78 M Rheumatoid arthritis Died 30 3,885 3
P32 54 M Crohn’s disease Survived 26 2,794 2
P34§ 63 M Sarcoidosis Died 19 2,979 2
P37 69 F Hashimoto’s thyroiditis Survived 22 3,510 0
P38 51 F Focal segmental glomerulosclerosis Died 20 >5,000 1
P39 69 M Idiopathic thrombocytopenic purpura Survived 19.5 610 1
Patients with solid organ transplant
P2 77 M Kidney transplant Survived 21 3,952 0
P3 67 F Kidney transplant Survived 26.5 1,290 0
P6 65 F Kidney transplant Survived 18 1,170 2
P7 69 F Kidney transplant Survived 15 3,400 0
P8*,$ 68 M Kidney transplant Survived 16 3,507 3
P13 58 M Kidney transplant Survived 26 4,075 0
P19 67 M Liver transplant Survived 18.5 3,410 2
P20 67 M Kidney transplant Survived 21 >5,000 1
P21 36 F Kidney transplant Survived 19 3,439 1
P22 58 M Kidney transplant Survived 23 4,094 0
P24 55 F Kidney transplant Survived 18 >5,000 2
P25 62 M Kidney transplant Survived 20 2,738 4
P27 33 M Kidney transplant Survived 25 2,330 1
P29 61 M Kidney transplant Survived 21 >5,000 2
P33 76 F Kidney transplant Survived 22 2057 5
P35 69 M Heart transplant Survived 24 >5,000 0
Patients with hematological malignancy
P4#,§ 58 F T-cell large granular lymphocyte leukemia Survived 26.5 2,771 1
P5 64 F Angioimmunoblastic T-cell lymphoma Survived 30 1900 2
P10§ 70 M Diffuse large B-cell lymphoma Died 28 269 1
P11 67 M Diffuse large B-cell lymphoma Survived 28.5 211 1
P12#,§ 56 M Burkitt lymphoma Died 19 1,478 0
P14 58 M Hodgkin lymphoma Survived 27.5 117 1
P16 57 M Mantle cell lymphoma Survived 26 <31 1
P17 26 M Hodgkin lymphoma Survived 26 <31 1
P28 67 M Hodgkin lymphoma Died 26 77 10
P30 44 F Chronic lymphocytic leukemia Survived 26.5 68 4
P31 78 F Mixed-phenotype acute leukemia Survived 34 1,557 0
Patients with solid cancer
P18 62 M Kidney cancer Survived 25 40 1
P23 75 M Squamous cell lung carcinoma Survived 23 395 0
P36 73 M Lung adenocarcinoma Died 18.5 2,890 0

BALF, bronchoalveolar lavage fluid; BG, (1,3)-β-D-glucan; Ct, cycle threshold; F, Female; M, Male.

*

Patients with concurrent invasive candidiasis.

#

Patients with concurrent gram-negative sepsis.

$

Patients receiving intravenous immunoglobulin therapy.

§

Patients receiving methotrexate administration.